Diabetic Retinopathy

Over 4 million individuals in the United States have Diabetic Retinopathy, the country’s leading cause of adult blindness. The numbers are increasing rapidly due to an increase in the incidence of both Type I (sometimes called “Juvenile Diabetes”) and Type II Diabetes. Effective, long-term treatment options are not available. Diabetic retinopathy happens when the disease damages the tiny blood vessels inside the retina. Early symptoms are often gradual and unnoticed.

Working to Improve Outcomes

Diabetic Retinopathy is one of VRC's focus areas of research. We collaborate with medical partners and members of the community to find new options that may prove effecitve in treating and managing the disease. 

Paul Tonga's Story and VRC's Impact

As a diabetic, Paul Tonga was no stranger to the eye doctor. He was diligent about his eye care. He came to the Vision Research Center after being referred by University Health Lakewood Medical Center where he had cataract surgery. Following the surgery, his eyesight had improved but one eye was still quite weak. At the Vision Research Center, the physicians used an experimental treatment with lasers to treat his eye.

“The treatment helped a lot. I believe it saved my vision. Because of it, I have maintained my independence and enjoy all the daily activities that were in danger of being lost.” Mr. Tonga adds, “I recommend the community gives to the Vision Research Foundation. It will go to a very important cause. Vision is one of the most important assets we have and its loss threatens millions of people. The Vision Research Center is committed to eliminating this threat. They have helped me greatly."